Menu

Question 1601

Topic: Biology, Genetics & Bone Healing

A 25-year-old man presents with progressive knee pain. Radiographs reveal an eccentric, entirely lytic epiphyseal lesion in the proximal tibia with no sclerotic border. A biopsy demonstrates sheets of mononuclear cells interspersed with numerous osteoclast-like giant cells. Due to the proximity to the joint, a specific monoclonal antibody is considered for systemic treatment prior to curettage to downstage the tumor. This medication exerts its effect by binding directly to which of the following?

. Receptor Activator of Nuclear factor Kappa-B (RANK)
. Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL)
. Osteoprotegerin (OPG)
. Vascular endothelial growth factor (VEGF)
. Macrophage colony-stimulating factor (M-CSF)

Correct Answer & Explanation

. Receptor Activator of Nuclear factor Kappa-B (RANK)


Explanation

The clinical and radiographic presentation of an eccentric, lytic epiphyseal lesion in a young adult is characteristic of a Giant Cell Tumor (GCT) of bone. Histologically, GCTs consist of neoplastic mononuclear stromal cells and reactive osteoclast-like giant cells. The neoplastic stromal cells overexpress Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL). RANKL normally binds to the RANK receptor on the surface of osteoclast precursors, stimulating their differentiation and activation. Denosumab is a fully human monoclonal antibody that directly binds to and neutralizes RANKL, preventing it from binding to RANK. This halts the recruitment of osteoclast-like giant cells, leading to decreased bone resorption, tumor necrosis, and peripheral ossification of the lesion.

Question 1602

Topic: Biology, Genetics & Bone Healing

An 18-year-old man sustains a transverse midshaft femur fracture that is surgically stabilized with an intramedullary nail, leaving a minor gap at the fracture site. This mechanical environment promotes secondary (indirect) bone healing. Following the initial inflammatory phase and soft callus formation, endochondral ossification begins. During the hard callus phase, which of the following types of bone is initially deposited by osteoblasts?

. Lamellar bone
. Woven bone
. Haversian bone
. Osteonal bone
. Plexiform bone

Correct Answer & Explanation

. Lamellar bone


Explanation

Secondary (indirect) bone healing occurs under conditions of relative stability and involves fracture callus formation. The process progresses through hematoma/inflammation, soft callus (fibrocartilage), hard callus, and remodeling. During the hard callus phase, osteoblasts rapidly deposit woven bone via endochondral and intramembranous ossification. Woven bone is characterized by a disorganized, random arrangement of collagen fibers, which allows it to be formed quickly to bridge the fracture gap but makes it mechanically weak. Over months to years, basic multicellular units (osteoclasts and osteoblasts) remodel this woven bone into highly organized, mechanically robust lamellar bone (which includes Haversian/osteonal systems).

Question 1603

Topic: Biology, Genetics & Bone Healing

A 45-year-old man undergoes a posterolateral lumbar fusion. Recombinant human bone morphogenetic protein-2 (rhBMP-2) is utilized. Which of the following best describes the intracellular signaling mechanism immediately following BMP binding to its receptor?

. Activation of the Wnt/beta-catenin pathway
. Phosphorylation of Smad 1, 5, and 8
. Inhibition of osteoprotegerin (OPG)
. Activation of adenylyl cyclase and cAMP production
. Cleavage of the Notch intracellular domain

Correct Answer & Explanation

. Activation of the Wnt/beta-catenin pathway


Explanation

BMPs are members of the TGF-beta superfamily. They bind to cell surface serine/threonine kinase receptors. Upon activation, these receptors phosphorylate intracellular Smad proteins, specifically Smad 1, 5, and 8. These phosphorylated Smads then form a complex with Smad 4, which translocates to the nucleus to regulate the transcription of osteogenic genes, including Runx2. The Wnt pathway involves beta-catenin, while OPG is a decoy receptor for RANKL.

Question 1604

Topic: Biology, Genetics & Bone Healing

A 65-year-old woman with severe osteoporosis requires spinal instrumentation. To maximize pedicle screw pull-out strength in osteoporotic bone, which of the following alterations in screw design is most effective?

. Decreasing the outer diameter of the screw
. Decreasing the thread pitch (fewer threads per inch)
. Increasing the inner diameter of the screw core
. Increasing the outer diameter of the screw
. Utilizing a screw with a constant inner diameter rather than conical

Correct Answer & Explanation

. Decreasing the outer diameter of the screw


Explanation

The pull-out strength of a pedicle screw is most significantly influenced by the outer diameter of the screw, the length of bone engagement, and the bone mineral density. Increasing the outer diameter increases the volume of bone caught between the threads, thereby maximizing pull-out strength. Increasing the inner diameter (core) decreases thread depth, which reduces pull-out strength but increases the fatigue strength of the screw. Decreasing thread pitch (fewer threads) decreases engagement and reduces pull-out resistance.

Question 1605

Topic: Biology, Genetics & Bone Healing

A 70-year-old man presents with aseptic loosening of his cementless total hip arthroplasty 15 years after the index procedure. Radiographs show extensive periprosthetic osteolysis. The primary biological mechanism involves particulate wear debris stimulating macrophages to release cytokines. Which of the following is the final common pathway leading to bone resorption in this condition?

. Increased production of Osteoprotegerin (OPG)
. Macrophage-mediated direct phagocytosis of bone
. Increased expression of RANKL binding to RANK on osteoclast precursors
. Decreased expression of Macrophage Colony-Stimulating Factor (M-CSF)
. Activation of the Wnt/beta-catenin pathway in osteoblasts

Correct Answer & Explanation

. Increased production of Osteoprotegerin (OPG)


Explanation

In periprosthetic osteolysis, wear debris (most notably polyethylene) is phagocytosed by macrophages. These activated macrophages release pro-inflammatory cytokines such as TNF-alpha, IL-1, and IL-6. These cytokines stimulate osteoblasts and other local cells to increase the expression of Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL). RANKL binds to the RANK receptor on osteoclast precursors, stimulating their differentiation and activation into mature, bone-resorbing osteoclasts.

Question 1606

Topic: Biology, Genetics & Bone Healing

A 35-year-old patient with a displaced transverse midshaft tibial fracture is treated with an intramedullary nail. The construct allows for a moderate amount of interfragmentary motion. According to Perren's strain theory, what type of tissue will primarily form in the fracture gap if the interfragmentary strain is between 2% and 10%?

. Woven bone
. Lamellar bone
. Cartilage
. Granulation tissue
. Fibrous tissue

Correct Answer & Explanation

. Woven bone


Explanation

Perren's strain theory states that the type of tissue that can form in a fracture gap depends on the local mechanical strain. Tissues cannot form if the strain exceeds their tolerance. Granulation tissue can tolerate up to 100% strain. Fibrous tissue can tolerate up to 17% strain. Cartilage tolerates strains between 2% and 10%. Bone formation requires very low strain environments; lamellar bone requires strain less than 2%. With 2% to 10% strain, a cartilaginous callus (endochondral ossification) will form.

Question 1607

Topic: Biology, Genetics & Bone Healing

A 45-year-old man undergoes a posterolateral lumbar fusion using a structural cortical allograft. What is the primary mechanism by which this structural allograft will incorporate over the next 12 months?

. Osteogenesis followed by osteoinduction
. Osteoconduction followed by creeping substitution
. Direct intramembranous ossification
. Endochondral ossification
. Osteoinduction followed by osteogenesis

Correct Answer & Explanation

. Osteogenesis followed by osteoinduction


Explanation

Structural allografts incorporate primarily through osteoconduction, acting as a scaffold for host bone growth. This is followed by creeping substitution, a process where host osteoclasts gradually resorb the graft and osteoblasts lay down new woven and lamellar bone. Allografts lack living osteogenic cells and have minimal osteoinductive potential compared to autografts, as the processing required to prevent rejection diminishes osteoinductive proteins.

Question 1608

Topic: Biology, Genetics & Bone Healing

A 35-year-old woman presents with severe knee pain. Radiographs reveal an eccentric, lytic, epiphyseal-metaphyseal lesion in the distal femur extending to the subchondral bone. Biopsy shows mononuclear cells and multinucleated giant cells. Which of the following describes the mechanism of action of the most appropriate targeted medical therapy for a recurrent or unresectable form of this disease?

. Inhibition of vascular endothelial growth factor (VEGF)
. Binding to the RANK ligand (RANKL) to prevent osteoclast activation
. Inhibition of tyrosine kinase receptors
. Binding to bisphosphonates to inhibit osteoblast apoptosis
. Direct alkylation of DNA in rapidly dividing cells

Correct Answer & Explanation

. Inhibition of vascular endothelial growth factor (VEGF)


Explanation

The patient has a giant cell tumor (GCT) of bone. Denosumab is a targeted monoclonal antibody used for unresectable or recurrent GCTs. The neoplastic cells in GCT are the mononuclear stromal cells, which express high levels of RANKL. Denosumab binds directly to RANKL, preventing it from binding to the RANK receptor on the reactive multinucleated giant cells (osteoclast precursors). This inhibits giant cell formation, function, and survival, leading to tumor suppression.

Question 1609

Topic: Biology, Genetics & Bone Healing

A 32-year-old woman presents with progressive knee pain and swelling. Radiographs display an eccentric, expansile, purely lytic lesion in the distal femoral epiphysis extending to the subchondral bone plate without a sclerotic margin. Histologic examination demonstrates a proliferation of neoplastic mononuclear stromal cells mixed with numerous multinucleated giant cells. For surgically unsalvageable or recurrent disease, targeted systemic therapy would appropriately focus on inhibiting which of the following molecular targets?

. Receptor activator of nuclear factor kappa-B ligand (RANKL)
. Platelet-derived growth factor receptor (PDGFR)
. Epidermal growth factor receptor (EGFR)
. Vascular endothelial growth factor (VEGF)
. Tyrosine kinase (TK)

Correct Answer & Explanation

. Receptor activator of nuclear factor kappa-B ligand (RANKL)


Explanation

The diagnosis is giant cell tumor of bone (GCTB), a locally aggressive benign bone tumor typically affecting the epiphyses of long bones in young adults. The pathogenesis relies on the neoplastic mononuclear stromal cells expressing high levels of RANKL, which recruits and activates the non-neoplastic, bone-resorbing multinucleated giant cells. Denosumab, a human monoclonal antibody that specifically binds to and inhibits RANKL, is an effective targeted therapy utilized for GCTB that is unresectable, recurrent, or would require highly morbid surgery.

Question 1610

Topic: Biology, Genetics & Bone Healing

Denosumab is a targeted biological therapy frequently used in the treatment of osteoporosis and giant cell tumor of bone. Which of the following best describes its specific mechanism of action?

. It binds to the RANK receptor on osteoclasts, directly stimulating apoptosis.
. It binds to RANKL, preventing the interaction between RANKL and RANK on osteoclast precursors.
. It acts as a decoy receptor similar to osteoprotegerin (OPG), binding directly to the osteoclast ruffled border.
. It inhibits farnesyl pyrophosphate synthase within the mevalonate pathway.
. It stimulates Wnt/beta-catenin signaling in osteoblasts to increase bone formation.

Correct Answer & Explanation

. It binds to the RANK receptor on osteoclasts, directly stimulating apoptosis.


Explanation

Denosumab is a fully human monoclonal antibody that specifically binds to receptor activator of nuclear factor kappa-B ligand (RANKL). By binding to RANKL, it prevents RANKL from activating its receptor, RANK, which is located on the surface of osteoclasts and their precursors. This inhibition prevents osteoclast formation, function, and survival, leading to decreased bone resorption. Bisphosphonates act by inhibiting farnesyl pyrophosphate synthase.

Question 1611

Topic: Biology, Genetics & Bone Healing

Bone morphogenetic proteins (BMPs) are potent osteoinductive growth factors utilized in spine fusion and fracture nonunions. Upon binding to their specific cell-surface serine/threonine kinase receptors, which primary intracellular signaling pathway is activated to promote osteoblast differentiation?

. Wnt/beta-catenin
. JAK/STAT
. Smad
. Notch
. Hedgehog

Correct Answer & Explanation

. Wnt/beta-catenin


Explanation

BMPs are members of the transforming growth factor-beta (TGF-beta) superfamily. When BMP binds to its heterodimeric cell-surface serine/threonine kinase receptor, it triggers the phosphorylation of intracellular receptor-regulated Smad proteins (primarily Smad1, Smad5, and Smad8). These phosphorylated Smads then form a complex with the co-Smad (Smad4), translocate into the nucleus, and regulate the transcription of target genes essential for osteoblast differentiation, such as Runx2. The Wnt pathway uses beta-catenin.

Question 1612

Topic: Biology, Genetics & Bone Healing

A 65-year-old woman is prescribed romosozumab for severe osteoporosis. This medication primarily increases bone mineral density through which of the following cellular mechanisms?

. Inhibition of RANK ligand
. Activation of the Wnt/beta-catenin pathway
. Direct stimulation of parathyroid hormone receptors
. Inhibition of osteoclast proton pumps
. Neutralization of Dickkopf-1 (DKK1)

Correct Answer & Explanation

. Inhibition of RANK ligand


Explanation

Romosozumab is a monoclonal antibody that binds and inhibits sclerostin. Sclerostin is an extracellular Wnt antagonist produced by osteocytes. By inhibiting sclerostin, romosozumab promotes Wnt binding to LRP5/6 receptors, thereby activating the canonical Wnt/beta-catenin signaling pathway, which enhances osteoblast differentiation and bone formation.

Question 1613

Topic: Biology, Genetics & Bone Healing

Bone morphogenetic proteins (BMPs) belong to the TGF-beta superfamily and play a critical role in osteoinduction. Which of the following intracellular signaling molecules is directly phosphorylated and activated by the BMP receptor upon ligand binding?

. STAT3
. MAPK
. Smad 1/5/8
. Beta-catenin
. NF-kB

Correct Answer & Explanation

. STAT3


Explanation

BMPs signal primarily through the canonical Smad pathway. When a BMP binds to its serine/threonine kinase receptor, the receptor phosphorylates and activates receptor-regulated Smads (R-Smads), specifically Smad 1, 5, and 8. These activated R-Smads then form a complex with the common-partner Smad (Co-Smad), Smad 4, and translocate to the nucleus to regulate the transcription of osteogenic target genes. In contrast, TGF-beta primarily signals through Smad 2 and 3.

Question 1614

Topic: Biology, Genetics & Bone Healing

A diaphyseal femur fracture is stabilized with a locked intramedullary nail. Which of the following modes of bone healing is expected to predominate?

. Primary bone healing through direct Haversian remodeling
. Secondary bone healing through callus formation
. Membranous ossification without an intermediate cartilage phase
. Creeping substitution
. Osteonal cutting cone formation

Correct Answer & Explanation

. Primary bone healing through direct Haversian remodeling


Explanation

Intramedullary nailing provides relative stability (as opposed to absolute stability achieved with compression plating). Relative stability allows for a small amount of interfragmentary motion (micromotion), which stimulates secondary bone healing. Secondary healing is characterized by the formation of a soft cartilaginous callus that eventually undergoes endochondral ossification to form a hard bony callus. Primary bone healing (direct Haversian remodeling with cutting cones) occurs only under conditions of absolute stability and anatomic reduction.

Question 1615

Topic: Biology, Genetics & Bone Healing

Osteoclasts resorb bone by creating an acidic environment in the sealed zone. Which of the following enzymes is primarily responsible for generating the hydrogen ions required for this process?

. Alkaline phosphatase
. Tartrate-resistant acid phosphatase (TRAP)
. Carbonic anhydrase II
. Cathepsin K
. Matrix metalloproteinase-9 (MMP-9)

Correct Answer & Explanation

. Alkaline phosphatase


Explanation

Carbonic anhydrase II catalyzes the intracellular conversion of carbon dioxide and water into carbonic acid, which then dissociates into hydrogen ions and bicarbonate. The hydrogen ions are pumped into the resorption pit by a V-type H+-ATPase to dissolve the inorganic bone mineral. Cathepsin K and MMPs are subsequently responsible for degrading the remaining organic matrix.

Question 1616

Topic: Biology, Genetics & Bone Healing

Nitrogen-containing bisphosphonates (e.g., alendronate) are commonly prescribed for osteoporosis. They primarily inhibit osteoclast function and induce apoptosis by interfering with which of the following intracellular pathways?

. RANK-RANKL binding interaction
. Mevalonate pathway via inhibition of farnesyl pyrophosphate (FPP) synthase
. Wnt/beta-catenin signaling pathway
. Sclerostin production by osteocytes
. Osteoprotegerin (OPG) secretion by osteoblasts

Correct Answer & Explanation

. RANK-RANKL binding interaction


Explanation

Nitrogen-containing bisphosphonates inhibit farnesyl pyrophosphate (FPP) synthase within the mevalonate pathway. This prevents the prenylation (lipid modification) of small GTP-binding proteins (like Ras, Rho, and Rab) that are essential for osteoclast ruffled border formation, function, and survival, ultimately leading to osteoclast apoptosis. Denosumab inhibits RANK-RANKL binding.

Question 1617

Topic: Biology, Genetics & Bone Healing

Primary (direct) bone healing relies on absolute stability and occurs without radiographically visible callus formation. Which of the following histologic features is characteristic of primary bone healing?

. Formation of a soft fibrocartilaginous callus
. Chondrocyte hypertrophy and apoptosis
. Formation of cutting cones crossing the fracture gap
. Endochondral ossification
. Deposition of woven bone in a high-strain environment

Correct Answer & Explanation

. Formation of a soft fibrocartilaginous callus


Explanation

Primary (direct) bone healing occurs via Haversian remodeling. This requires absolute stability and direct bone-to-bone contact. Osteoclasts at the leading edge of a 'cutting cone' tunnel across the fracture line, followed immediately by osteoblasts that lay down new lamellar bone, directly bridging the gap. There is no intermediate cartilaginous phase or visible callus.

Question 1618

Topic: Biology, Genetics & Bone Healing

Which of the following genetic mutations is most likely to cause infantile malignant osteopetrosis due to the inability of osteoclasts to acidify the Howship lacuna?

. TCIRG1
. COL1A1
. FGFR3
. RUNX2
. SOX9

Correct Answer & Explanation

. TCIRG1


Explanation

Osteopetrosis is caused by defective osteoclast function resulting in failure of bone resorption. The most common autosomal recessive form (infantile malignant) is primarily due to a mutation in the TCIRG1 gene, which encodes the a3 subunit of the vacuolar H+-ATPase (V-ATPase) pump. This pump is essential for secreting hydrogen ions to acidify the resorption pit (Howship lacuna). COL1A1 mutations cause osteogenesis imperfecta. FGFR3 mutations lead to achondroplasia. RUNX2 mutations are associated with cleidocranial dysplasia. SOX9 mutations result in campomelic dysplasia.

Question 1619

Topic: Biology, Genetics & Bone Healing

Sclerostin is a key regulatory glycoprotein produced primarily by mature osteocytes. It reduces bone formation by antagonizing which of the following intracellular signaling pathways?

. BMP / Smad pathway
. Wnt / β-catenin pathway
. RANK / RANKL pathway
. Notch / Hes pathway
. Hedgehog / Gli pathway

Correct Answer & Explanation

. BMP / Smad pathway


Explanation

Sclerostin, encoded by the SOST gene, is a potent inhibitor of bone formation. It functions by binding to the LRP5/6 coreceptors on the surface of osteoblasts, which competitively inhibits the binding of Wnt ligands. This prevents the activation of the canonical Wnt/β-catenin signaling pathway, leading to decreased osteoblast proliferation and function. Monoclonal antibodies targeting sclerostin, such as romosozumab, are utilized to treat severe osteoporosis.

Question 1620

Topic: Biology, Genetics & Bone Healing

A 65-year-old postmenopausal woman with severe osteoporosis is treated with denosumab to reduce her fracture risk. Which of the following describes the precise mechanism of action of this medication in modulating bone metabolism?

. It binds directly to the RANK receptor on osteoclasts, inhibiting their activation.
. It acts as an endogenous decoy receptor for RANKL, similar in structure to osteoprotegerin.
. It binds to RANKL, preventing its subsequent interaction with the RANK receptor.
. It inhibits the enzyme cathepsin K, reducing the breakdown of type I collagen.
. It directly stimulates the Wnt/beta-catenin signaling pathway in osteoblasts.

Correct Answer & Explanation

. It binds directly to the RANK receptor on osteoclasts, inhibiting their activation.


Explanation

Denosumab is a fully human monoclonal antibody that specifically targets and binds to RANKL (Receptor Activator of Nuclear factor Kappa-B Ligand). By binding to RANKL, denosumab prevents it from interacting with the RANK receptor on the surface of osteoclasts and their precursors. This effectively inhibits osteoclast formation, function, and survival, leading to decreased bone resorption. Osteoprotegerin (OPG) is the body's natural decoy receptor for RANKL, but denosumab itself is an antibody, not a decoy receptor.